SHORT REPORTS Lead hazard in British stained glass workers
Few studies have been undertaken into lead exposure among stained glass workers. In a recent survey of a studio in the United States Landrigan and his colleagues concluded that the blood lead concentrations were within acceptable limits for occupational exposure. ' We have surveyed four stained glass workshops, the largest in Britain, and found that the potential for lead exposure is greater than previously recognised. All the workshops manufactured stained glass and restored windows in churches and other historical buildings; two were attached to cathedrals.
Materials, methods, and results
A questionnaire was administered to each worker to ascertain job details (including use of protective clothing and masks), personal habits (smoking and nail biting), and symptoms of lead poisoning. Venous blood samples were analysed for lead at the Health and Safety Executive's occupational medicine and hygiene laboratories, which participate in a national quality control scheme. At the largest workshop five background and five personal air samples were obtained during one day while glazing work was performed, and personal samplers were worn by two men on a day when they removed a stained glass window from a historic building.
Altogether 47 exposed workers (39 men and eight women) took part and there was only one refusal. The table shows the distribution of blood lead concentrations; the mean was 14 ,umol/l (30 I.lg/ 100 ml) (range 0*5-3 4 ,umol/l; 10-70 ,ug/100 ml). Nine workers had concentrations of 1-9 Hmol/l (40 Htg/100 ml) or over, including one woman of reproductive age who had to be temporarily suspended from work with lead in accordance with the British approved code of practice2; she worked entirely inside the workshop as a glazier. There were no symptoms of lead toxicity. No Suspension concentration for women 1 9 .Lmol/l (40 ±Lg/lO0 ml), for men 3-9 ILmol/l (80 ILg/100 ml).
Comment
The inhalation of fume or dust containing lead was unlikely by itself to account for the blood lead values exceeding 1-9 ,umol/l (40 pg/100 ml) in nine (19%) of the workers studied. We observed that exposure to lead could also occur by ingestion as a result of neglect of basic hygiene precautions-for example, eating and smoking were not always prohibited in areas of lead work, and handwashing facilities were often unavailable on outside sites such as small churches. Few workers perceived that lead was an occupational hazard for them.
Stained glass workers should heed warnings about lead,34 and British firms should be reminded about making formal assessments of their work practices as required by the regulations on control of lead at work and described in the approved code ofpractice.' We recommend a blood lead examination at least yearly. Symptoms of lead poisoning may occasionally arise at blood lead concentrations below 3 9 pmol/l (80 jLg/100 ml), the current value at which male lead workers in Britain are suspended from work.' In order to protect the fetus women workers of reproductive age are suspended from work when their blood lead concentrations reach 1-9 imol/l (40 jAg/100 Ml)2; our findings suggest that this concentration may be readily exceeded. Working with stained glass is becoming an increasingly popular pursuit among both sexes, and it is therefore important that the hazards of excessive lead absorption and its prevention, particularly as they apply to women, should be more widely understood.
We are indebted to the workers and firms who participated in this study. This study shows that, in addition to the fear of war, problems of immediate and more personal relevance such as unemployment, poverty, and, especially in girls, unhappy marriages are major concerns of English adolescents. The effects, if any, of these anxieties on the mental and physical health of adolescents are unknown, but the high prevalence of these anxieties suggests that the effects on health of unemployment may extend to those who are at risk of unemployment.
We thank the Health Education Council for supporting this work; the Nottinghamshire education department and the assistant director of education, Mr Peter Housden; and the schools and pupils who participated in this study.
Rapid estimation of plasma theophylline concentrations
Methyl xanthines are used in the treatment of both chronic airways obstruction and asthma. As they have a narrow therapeutic index a knowledge of their plasma concentration is helpful in optimising their clinical effect while avoiding side effects.' It is sometimes desirable to give parenteral methyl xanthines in an emergency, but without knowledge of the patient's plasma theophylline concentration this can be hazardous. In outpatients an increase in theophylline dosage may be clinically desirable but has to be delayed until the plasma concentration is known, which is often not until the patient's next visit. Though 
Patients, methods, and results
We measured plasma theophylline concentrations in 65 consecutive patients attending our outpatient clinics who had been prescribed a methyl xanthine preparation. Samples were analysed by two different operators using a Seralyser and compared with samples taken simultaneously and assayed by a fluorescence polarisation immunoassay (Abbott TDX).
Venous blood (10 ml) was removed from each patient and centrifuged and the plasma separated into three aliquots. One was sent for independent assay, and the two others were diluted for immediate estimation of the theophylline concentration. The reagent strip was placed on the stage of the photometer and 30 p.l diluted plasma pipetted on to it. The photometer was activated, the stage replaced, and the result displayed 80 seconds later. If the plasma concentration was lower than 3 mg/l the machine reported it as zero; if it was greater than 30 mg/l a further dilution had to be performed. The Seralyser was calibrated with two standard concentrations fortnightly and was checked with an intermediate standard (15 mg/I) before each outpatient session. Fifty of the patients had measurable concentrations (that is, >3 mg/i).
There was a good correlation between the analyses performed by each of the two operators using the Seralyser and the reference assay in the 50 patients with measurable concentrations (figure). The slopes of the regression lines were 1-02 and 0.99 respectively, and these lines were not significantly different from the line of identity. The 95% confidence limits about the regression lines were 1 9 and 2-0 mg/l respectively. The coefficient of variation of repeated measurements for the Seralyser at 15 mg/l was between 4% and 5%.
Plasma concentrations in the remaining 15 patients were all recognised by the Seralyser as being below 3 mg/l. Thus there were no false positive results. 
Comment
This technique of estimating plasma theophylline concentrations gives good results within five minutes, even when used by relatively inexperienced operators outside a chemical pathology laboratory. It has been suggested that measuring plasma theophylline concentrations adds little to the clinical benefit of administration of methyl xanthines,3 and this is probably the case when the result is delayed. We believe that the therapeutic effect of theophylline could be achieved with more speed and certainty by monitoring drug concentrations with a rapid technique. Certainly, immediate estimation of plasma theophylline concentrations would facilitate safer and more confident use of parenteral theophylline in casualty departments. Probably, therefore, the ready availability of plasma theophylline concentrations would lead to more rational and safer use of methyl xanthine preparations.
